fluorescein-5-isothiocyanate has been researched along with glycyl-arginyl-glycyl-aspartyl-seryl-proline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frojmovic, MM; Xia, Z | 1 |
Chung, KH; Hwang, KA; Kim, TJ; Lee, YH; Ryu, CK; Song, YS; Yun, YP; Zhang, YH | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and glycyl-arginyl-glycyl-aspartyl-seryl-proline
Article | Year |
---|---|
Aggregation efficiency of activated normal or fixed platelets in a simple shear field: effect of shear and fibrinogen occupancy.
Topics: Blood Platelets; Fibrinogen; Fluorescein-5-isothiocyanate; Humans; In Vitro Techniques; Kinetics; Oligopeptides; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Binding | 1994 |
Antiplatelet mechanism of 2-chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone (NQ304), an antithrombotic agent.
Topics: Adenosine Triphosphate; Arachidonic Acid; Calcium; Dose-Response Relationship, Drug; Fibrinogen; Fluorescein-5-isothiocyanate; Humans; Naphthoquinones; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Signal Transduction; Thapsigargin; Thrombin; Thromboxane A2 | 2001 |